CA3147649C - Derive de pyrazole et son utilisation - Google Patents

Derive de pyrazole et son utilisation

Info

Publication number
CA3147649C
CA3147649C CA3147649A CA3147649A CA3147649C CA 3147649 C CA3147649 C CA 3147649C CA 3147649 A CA3147649 A CA 3147649A CA 3147649 A CA3147649 A CA 3147649A CA 3147649 C CA3147649 C CA 3147649C
Authority
CA
Canada
Prior art keywords
compound
group
cancer
kinase inhibitor
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3147649A
Other languages
English (en)
Other versions
CA3147649A1 (fr
Inventor
Qing Song LIU
Jing Liu
Xi Xiang LI
Ao Li WANG
Feng Ming ZOU
Cheng Chen
Qing Wang LIU
Juan Liu
Jiang Yan CAO
Wen Liang Wang
Shuang QI
Wen Chao WANG
Bei Lei WANG
Li Wang
Original Assignee
Tarapeutics Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tarapeutics Science Inc filed Critical Tarapeutics Science Inc
Priority claimed from PCT/CN2020/109130 external-priority patent/WO2021036814A1/fr
Publication of CA3147649A1 publication Critical patent/CA3147649A1/fr
Application granted granted Critical
Publication of CA3147649C publication Critical patent/CA3147649C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne un nouvel inhibiteur de kinase PDGFR, comprenant un composé de formule (I) ou un sel pharmaceutiquement acceptable, solvate, ester, acide, métabolite ou promédicament de celui-ci. L'invention concerne en outre l'utilisation et un procédé du composé de formule (I) pour la prévention ou le traitement d'états associés à l'activité de la kinase PDGFR, en particulier l'utilisation et un procédé pour la prévention ou le traitement d'états associés à l'activité de la kinase PDGFR? et/ou PDGFR?.
CA3147649A 2019-08-29 2020-08-14 Derive de pyrazole et son utilisation Active CA3147649C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201910807395 2019-08-29
CN201910807395.9 2019-08-29
PCT/CN2020/109130 WO2021036814A1 (fr) 2019-08-29 2020-08-14 Dérivé de pyrazole et son utilisation

Publications (2)

Publication Number Publication Date
CA3147649A1 CA3147649A1 (fr) 2021-03-04
CA3147649C true CA3147649C (fr) 2025-07-22

Family

ID=

Similar Documents

Publication Publication Date Title
CN104936944B (zh) 作为酪氨酸激酶抑制剂的吲哚满酮衍生物
WO2019174601A1 (fr) Composés hétéroaryle utilisés en tant qu'inhibiteur de kinase
KR20160117605A (ko) 피롤 치환된 인돌론 유도체, 이의 제조방법, 이를 함유하는 조성물 및 이의 용도
US12115152B2 (en) Pan-RAF kinase inhibitor and use thereof
KR102778078B1 (ko) 피라졸 유도체 및 이의 용도
CA3147649C (fr) Derive de pyrazole et son utilisation
RU2805207C1 (ru) Производные пиразола и их применение
CN109796456A (zh) 新的抗癌化合物及其用途
EP3896059B1 (fr) Inhibiteur de kinase pan-kit ayant une structure quinoléine et son utilisation
JP7176798B2 (ja) インダゾールキナーゼ阻害剤及びその使用
CN110283160B (zh) 一种pdgfr激酶抑制剂
RU2792626C1 (ru) Новый ингибитор киназы pan-raf и его применение
HK40052071B (en) Pan-kit kinase inhibitor having quinoline structure and application thereof